The Veterinary Anti Infectives Market to Grow Based On Digitized Innovation in Healthcare

The Veterinary Anti Infectives Market is all set to go great guns in the forecast period. Big data makes way for real-time data visualization, thereby identifying the high-risk populations. Healthcare organizations are into sharing more data. This creation and collection of bigger datasets are likely to increase precision and help organizations in spotting trends. These trends are expected to keep the entire healthcare vertical on the toes.

In recent years, reports of deadly animal disease outbreaks have become more recurrent. These diseases are not only a threat to the existence of many wild species but also lead to substantial livestock losses.

The prevention and treatment of such diseases are key market indicators for veterinary therapeutics including veterinary anti-infectives. In its latest report, Persistence Market Research has projected that the global veterinary anti-infectives market will expand at a CAGR of 4.1% over the forecast period (2017-2025) and reach a valuation of US$ 5,221.2 Mn by 2025-end.

Get Going With Sample Of Veterinary Anti Infectives Market Report! https://www.persistencemarketresearch.com/samples/17014

Company Profiles

Bayer AG
Cipla Limited
Dechra Pharmaceuticals PLC
Eli Lilly and Company (Elanco Animal Health)
Heska Corp (Diamond Animal Health)
Merck & Co., Inc. (Merck Animal Health)
Neogen Corporation
Phibro Animal Health Corporation
Sanofi (Merial Animal Health)
Vetoquinol S.A.
Virbac S.A.
Zoetis, Inc.
Boehringer Ingelheim GmbH
Ceva Santé Animale
Indian Immunologicals Limited
Intas Pharmaceuticals Limited
Norbrook Laboratories Limited
Zydus Animal Health Limited
Ashish Life Science Private Limited
Oceanic Pharmachem Private Limited.

How About Re-Inventing The Methodical Wheel In The Veterinary Anti Infectives Market? Switch Over To The "Methodology" Tab! https://www.persistencemarketresearch.com/methodology/17014

Increasing demand for anti-microbial agents is expected to contribute significantly towards the growth of market revenue in the near future. The rise in livestock population can boost the demand for veterinary therapeutics globally.

In 2014, the Food and Agriculture Organization of the United Nations estimated the global cattle count at over 1.5 billion. These figures are further expected to grow substantially due to rapidly growing demand for livestock.

North America to Remain the Frontrunner in the Global Veterinary Anti-Infective Market

North America is currently the largest veterinary anti-infectives market and is estimated to represent 30.5% value share of the global market by 2025-end, expanding at CAGR of 3.7%.

This growth is primarily attributed to the increase in pet ownership and demand for high-quality meat in the U.S. and Canada. Meanwhile, Latin America will continue to be the second most attractive market during the forecast period. The market in Asia Pacific (APAC) is projected to witness the fastest growth over 2025.

Keeping A Tab On Key Players In The Veterinary Anti Infectives Market? Go To "Purchase Now" To Decipher The Competitive Analysis In Our Veterinary Anti Infectives Market Report! https://www.persistencemarketresearch.com/checkout/17014

Additional Highlights of the Report Include:

Based on species types, use of veterinary anti-infectives medicines is relatively higher on livestock animals as compared to pet animals. In 2016, livestock animals accounted for more than 68% market value share, however, this figure is likely to drop to 67.4% by 2025 end.

Antimicrobial agents currently are the most preferred drug type. By the end of forecast period, antimicrobial agents are expected to command for 54.6% value share of the market. Other drugs such as antifungal agents and antiviral agents are also gaining traction owing to product improvement and effectiveness.

Based on modes of administration, the oral route is presently the most common drug administration mode followed by the parenteral route. By the end of 2025, the oral administration segment is projected to reach a market valuation of US$ 1,573.1 Mn.

Veterinary clinics are projected to reaming the leading distribution channel for veterinary anti-infectives in 2017 and beyond. Of late, veterinary hospitals and pharmacies have emerged as the other two key distribution channels for various veterinary drugs including anti-infectives.

Access Related Reports-

Shrimp Disease Diagnostics Market: https://www.persistencemarketresearch.com/market-research/shrimp-disease-diagnostics-market.asp

Us Animal Drug Compounding Market: https://www.persistencemarketresearch.com/market-research/us-animal-drug-compounding-market.asp

Contact Us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Website - https://www.persistencemarketresearch.com

About Us:

Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.

This release was published on openPR.